Total Payments
$111,914
2024 Payments
$2,734
Companies
50
Transactions
1,053
Medicare Patients
32,409
Medicare Billing
$6.8M
Payment Breakdown by Category
Other$50,400 (45.0%)
Consulting$41,514 (37.1%)
Food & Beverage$18,524 (16.6%)
Travel$1,249 (1.1%)
Education$226.16 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $41,600 | 24 | 37.2% |
| Consulting Fee | $41,514 | 19 | 37.1% |
| Food and Beverage | $18,524 | 979 | 16.6% |
| Honoraria | $8,800 | 8 | 7.9% |
| Travel and Lodging | $1,249 | 10 | 1.1% |
| Education | $226.16 | 13 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| CVRx, Inc. | $37,213 | 59 | $0 (2024) |
| Impulse Dynamics (USA) Inc. | $23,582 | 81 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $11,577 | 89 | $0 (2024) |
| PFIZER INC. | $8,572 | 83 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $7,284 | 130 | $0 (2024) |
| CardioFocus, Inc. | $6,030 | 9 | $0 (2020) |
| Abbott Laboratories | $5,553 | 28 | $0 (2024) |
| BIOTRONIK INC. | $2,113 | 86 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,528 | 86 | $0 (2024) |
| Boston Scientific Corporation | $1,376 | 27 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,734 | 133 | Novartis Pharmaceuticals Corporation ($357.78) |
| 2023 | $15,015 | 173 | CVRx, Inc. ($9,900) |
| 2022 | $33,451 | 172 | Impulse Dynamics (USA) Inc. ($21,075) |
| 2021 | $6,152 | 109 | CVRx, Inc. ($4,669) |
| 2020 | $995.28 | 63 | Novartis Pharmaceuticals Corporation ($192.26) |
| 2019 | $14,827 | 110 | CardioFocus, Inc. ($6,000) |
| 2018 | $8,282 | 141 | Abbott Laboratories ($2,464) |
| 2017 | $30,458 | 152 | CVRx, Inc. ($12,173) |
All Payment Transactions
1,053 individual payment records from CMS Open Payments — Page 1 of 43
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $26.79 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/16/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $22.66 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/12/2024 | Impulse Dynamics (USA) Inc. | Optimizer (Device), Optimizer | Food and Beverage | Cash or cash equivalent | $17.89 | General |
| Category: Cardiovascular Device | ||||||
| 12/10/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $20.77 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/05/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $23.23 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 12/04/2024 | BIOTRONIK INC. | AMVIA EDGE (Device) | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/03/2024 | Alnylam Pharmaceuticals Inc. | AMVUTTRA (Drug) | Food and Beverage | In-kind items and services | $19.32 | General |
| Category: Genetic Disease | ||||||
| 12/02/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $29.55 | General |
| Category: Cardiology | ||||||
| 12/02/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $19.33 | General |
| Category: Cardiovascular | ||||||
| 11/27/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $29.62 | General |
| Category: Cardiology | ||||||
| 11/21/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $22.82 | General |
| Category: Obesity | ||||||
| 11/19/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $33.44 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/18/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $19.60 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/13/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $17.54 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/11/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $19.66 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/06/2024 | Impulse Dynamics (USA) Inc. | Optimizer (Device), Optimizer | Food and Beverage | Cash or cash equivalent | $19.19 | General |
| Category: Cardiovascular Device | ||||||
| 11/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.58 | General |
| Category: DIABETES | ||||||
| 11/05/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $3.27 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 11/04/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $33.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/01/2024 | Impulse Dynamics (USA) Inc. | Optimizer (Device), Optimizer | Food and Beverage | Cash or cash equivalent | $5.07 | General |
| Category: Cardiovascular Device | ||||||
| 10/31/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $22.76 | General |
| Category: Cardiovascular | ||||||
| 10/28/2024 | Edwards Lifesciences Corporation | EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) (Device) | Food and Beverage | In-kind items and services | $19.97 | General |
| Category: Transcatheter Heart Valves | ||||||
| 10/24/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $26.42 | General |
| Category: Diabetes | ||||||
| 10/23/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $21.09 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/23/2024 | Impulse Dynamics (USA) Inc. | Optimizer (Device), Optimizer | Food and Beverage | Cash or cash equivalent | $18.01 | General |
| Category: Cardiovascular Device | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 48 | 8,634 | 27,401 | $7.0M | $1.7M |
| 2022 | 52 | 8,580 | 27,765 | $6.9M | $1.8M |
| 2021 | 51 | 8,756 | 28,650 | $7.0M | $2.0M |
| 2020 | 54 | 6,439 | 15,428 | $5.2M | $1.3M |
Total Patients
32,409
Total Services
99,244
Medicare Billing
$6.8M
Procedure Codes
211
All Medicare Procedures & Services
211 procedure records from CMS Medicare Utilization — Page 1 of 9
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 1,771 | 10,089 | $1.2M | $349,880 | 28.7% |
| 33285 | Insertion of heart rhythm monitor under skin | Office | 2023 | 92 | 92 | $1.1M | $306,615 | 26.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 749 | 2,372 | $873,265 | $208,071 | 23.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 714 | 1,300 | $745,498 | $183,971 | 24.7% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 200 | 1,518 | $224,396 | $51,737 | 23.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 261 | 387 | $202,363 | $49,201 | 24.3% |
| 93298 | Evaluation of cardiac rhythm monitor system, remote up to 30 days | Office | 2023 | 304 | 2,490 | $199,276 | $47,542 | 23.9% |
| 93297 | Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | Office | 2023 | 220 | 1,963 | $155,170 | $38,225 | 24.6% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 243 | 687 | $160,770 | $37,877 | 23.6% |
| 93229 | Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | Office | 2023 | 52 | 52 | $127,016 | $31,997 | 25.2% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2023 | 229 | 259 | $140,119 | $31,816 | 22.7% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2023 | 184 | 187 | $129,030 | $31,674 | 24.5% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 89 | 89 | $114,601 | $29,891 | 26.1% |
| 93285 | Programming of cardiac rhythm monitor system | Office | 2023 | 266 | 647 | $117,520 | $27,703 | 23.6% |
| 93975 | Complete ultrasound of abdomen and pelvis artery and vein blood flow | Office | 2023 | 132 | 137 | $106,215 | $27,089 | 25.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 108 | 435 | $99,180 | $26,513 | 26.7% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 182 | 183 | $102,133 | $22,741 | 22.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 110 | 135 | $68,696 | $18,031 | 26.2% |
| 93656 | Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | Facility | 2023 | 22 | 24 | $65,680 | $17,340 | 26.4% |
| 93978 | Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | Office | 2023 | 146 | 149 | $78,378 | $16,852 | 21.5% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 228 | 718 | $64,582 | $15,256 | 23.6% |
| 33208 | Insertion of pacemaker and upper and lower heart chamber electrode | Facility | 2023 | 44 | 44 | $66,213 | $14,426 | 21.8% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2023 | 88 | 176 | $237,952 | $13,414 | 5.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 114 | 114 | $55,422 | $12,359 | 22.3% |
| 99453 | Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | Office | 2023 | 736 | 736 | $26,507 | $10,124 | 38.2% |
About Dr. Rodrigo Chan, MD
Dr. Rodrigo Chan, MD is a Cardiovascular Disease healthcare provider based in Mesa, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1659349512.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rodrigo Chan, MD has received a total of $111,914 in payments from pharmaceutical and medical device companies, with $2,734 received in 2024. These payments were reported across 1,053 transactions from 50 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($41,600).
As a Medicare-enrolled provider, Chan has provided services to 32,409 Medicare beneficiaries, totaling 99,244 services with total Medicare billing of $6.8M. Data is available for 4 years (2020–2023), covering 211 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Clinical Cardiac Electrophysiology, Nuclear Medicine
- Location Mesa, AZ
- Active Since 03/08/2006
- Last Updated 10/08/2025
- Taxonomy Code 207RC0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1659349512
Products in Payments
- Barostim Neo System (Device) $37,213
- Optimizer (Device) $21,356
- ELIQUIS (Drug) $15,238
- XARELTO (Drug) $11,577
- EnSite Velocity System Expansion Modules (Device) $2,930
- OPTIMIZER (Device) $2,189
- EnSite Velocity System Mapping Disposables (Device) $1,404
- ENTRESTO (Drug) $1,177
- WATCHMAN (Device) $1,078
- LifeVest (Device) $884.38
- EP Guiding Introducers (Device) $863.50
- VERQUVO (Drug) $670.21
- Ozempic (Drug) $644.48
- Assure WCD (Device) $588.49
- MULTAQ (Drug) $475.96
- JARDIANCE (Drug) $377.90
- LEQVIO (Drug) $350.28
- ZIO Patch (Device) $343.76
- VYNDAQEL (Drug) $270.69
- FARXIGA (Drug) $221.44
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Mesa
Andrew Kaplan, M.d, M.D
Cardiovascular Disease — Payments: $252,697
Cardiovascular Disease $252,697
Edgardo Zavala Alarcon, Md, MD
Cardiovascular Disease — Payments: $139,948
Cardiovascular Disease $139,948
Dr. Ambrose Panico, D.o, D.O
Cardiovascular Disease — Payments: $102,124
Cardiovascular Disease $102,124
Dr. Alphonse Ambrosia, D.o, D.O
Cardiovascular Disease — Payments: $72,284
Cardiovascular Disease $72,284
Dr. Satya Atmakuri, M.d, M.D
Cardiovascular Disease — Payments: $40,043
Cardiovascular Disease $40,043
Mark Stern, Md, MD
Cardiovascular Disease — Payments: $20,270
Cardiovascular Disease $20,270